...
首页> 外文期刊>Neuropsychopharmacology >Attenuation of Cue-Controlled Cocaine-Seeking by a Selective D3 Dopamine Receptor Antagonist SB-277011-A
【24h】

Attenuation of Cue-Controlled Cocaine-Seeking by a Selective D3 Dopamine Receptor Antagonist SB-277011-A

机译:选择性D3多巴胺受体拮抗剂SB-277011-A对提示控制可卡因的衰减

获取原文
           

摘要

Conditioned stimuli (CS) previously paired with drugs of abuse can elicit cravings in humans, relapse to drug use, and can also reinforce drug-seeking behavior in both humans and animals, events that are believed to be subserved in part by activation of the mesolimbic dopamine system. Converging anatomical, pharmacological, and behavioral evidence implicates dopamine D3 receptors in the mechanisms underlying cue-controlled behaviors. The purpose of the present study was therefore to investigate the effects on cocaine-seeking behavior of a novel D3 receptor antagonist, SB-277011-A, which is 100-fold more selective for D3 over D2 dopamine receptors. We have established previously that second-order schedules of reinforcement provide an animal model of cue-controlled drug-seeking both prior to and after cocaine has been self-administered. SB-277011-A dose-dependently decreased cocaine-seeking maintained by a cocaine-associated conditioned reinforcer in both the first, drug-free interval and also following self-administration of cocaine. At higher doses, SB-277011-A also increased the latency to receive the first CS presentation and cocaine infusion, thereby decreasing the number of cocaine infusions self-administered under the second-order schedule of reinforcement. SB-277011-A had no effect on cocaine intake under an FR-1 schedule of reinforcement, or on responding for sucrose under a second-order schedule of reinforcement, at any dose tested. These results therefore suggest that D3 dopamine receptors may be critically involved in cue-controlled drug-seeking behavior independently of any interaction with the reinforcing effects of cocaine itself, and may therefore provide a therapeutic target in the treatment of relapse to cocaine use induced by CSs.
机译:先前与滥用药物搭配使用的条件刺激(CS)可以引起人类的渴望,药物使用的复发,还可以增强人类和动物的寻毒行为,这些事件被认为部分是由于中脑边缘的激活而得到了缓解多巴胺系统。越来越多的解剖学,药理学和行为学证据暗示多巴胺D3受体参与提示控制行为的潜在机制。因此,本研究的目的是研究新型D3受体拮抗剂SB-277011-A对可卡因寻求行为的影响,其对D3的选择性比D2多巴胺受体高100倍。我们先前已经确定,二级补充时间表可在可卡因自行给药之前和之后提供提示控制药物寻找的动物模型。 SB-277011-A在第一个无药物间隔以及在可卡因自用后,可卡因相关的条件增强剂维持的剂量依赖性地降低了可卡因寻求。在较高剂量下,SB-277011-A还增加了接受第一次CS表现和可卡因输注的潜伏期,从而减少了在第二阶段强化治疗下自行给药的可卡因输注次数。在任何测试剂量下,SB-277011-A在FR-1强化方案下对可卡因的摄入量无影响,或在二级强化方案下对蔗糖的反应无影响。因此,这些结果表明,D3多巴胺受体可独立于与可卡因本身的增强作用的任何相互作用而完全参与提示控制的药物寻找行为,因此可为治疗CS诱导的可卡因使用复发提供治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号